KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Shares Outstanding (Weighted Average) (2016 - 2025)

Astrana Health's Shares Outstanding (Weighted Average) history spans 13 years, with the latest figure at $46.5 million for Q3 2023.

  • For Q3 2023, Shares Outstanding (Weighted Average) rose 3.91% year-over-year to $46.5 million; the TTM value through Sep 2023 reached $46.5 million, up 3.91%, while the annual FY2020 figure was $36.5 million, 5.24% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2023 was $46.5 million at Astrana Health, up from $44.8 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $46.5 million in Q3 2023 and bottomed at $34.5 million in Q1 2019.
  • The 4-year median for Shares Outstanding (Weighted Average) is $35.4 million (2019), against an average of $37.8 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) rose 6.4% in 2019 before it rose 3.91% in 2023.
  • A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $34.7 million in 2019, then increased by 5.24% to $36.5 million in 2020, then rose by 22.63% to $44.8 million in 2022, then rose by 3.91% to $46.5 million in 2023.
  • Per Business Quant, the three most recent readings for ASTH's Shares Outstanding (Weighted Average) are $46.5 million (Q3 2023), $44.8 million (Q3 2022), and $36.5 million (Q4 2020).